Holen Sie sich die Stockscreener-App
18.27
1.03%
-0.19
Handel nachbörslich:
17.91
-0.36
-1.97%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ENOV?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$18.46
Offen:
$18.51
24-Stunden-Volumen:
1.09M
Relative Volume:
0.77
Marktkapitalisierung:
$1.05B
Einnahmen:
$2.28B
Nettoeinkommen (Verlust:
$-1.13B
KGV:
-0.9199
EPS:
-19.86
Netto-Cashflow:
$35.92M
1W Leistung:
+0.16%
1M Leistung:
-25.70%
6M Leistung:
-19.69%
1J Leistung:
-39.78%
1-Tages-Spanne:
$18.08
$18.70
1-Wochen-Bereich:
$17.68
$18.79
52-Wochen-Spanne:
$17.30
$34.28
Enovis Corp Stock (ENOV) Company Profile
Firmenname
Enovis Corp
Sektor
Branche
Telefon
(302) 252-9160
Adresse
2711 CENTERVILLE ROAD, WILMINGTON
Compare ENOV vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
18.27 | 1.06B | 2.28B | -1.13B | 35.92M | -19.86 |
ABT
Abbott Laboratories
|
98.83 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.29 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.39 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.65 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.32 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-17 | Fortgesetzt | William Blair | Outperform |
| 2026-01-06 | Eingeleitet | BTIG Research | Buy |
| 2024-10-03 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-06-13 | Eingeleitet | JP Morgan | Neutral |
| 2024-02-13 | Eingeleitet | Stephens | Overweight |
| 2024-01-22 | Eingeleitet | UBS | Buy |
| 2024-01-03 | Eingeleitet | William Blair | Outperform |
| 2023-12-15 | Bestätigt | Needham | Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-06-26 | Eingeleitet | Needham | Buy |
| 2023-05-12 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-10-11 | Eingeleitet | Goldman | Buy |
| 2022-09-12 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-09-12 | Eingeleitet | Evercore ISI | Outperform |
| 2022-06-28 | Eingeleitet | Argus | Hold |
| 2022-06-27 | Fortgesetzt | Loop Capital | Buy |
| 2022-06-16 | Eingeleitet | Wells Fargo | Equal Weight |
Alle ansehen
Enovis Corp Aktie (ENOV) Neueste Nachrichten
Enovis Corporation (ENOV) Stock forecasts - Yahoo Finance Singapore
Enovis Corporation (ENOV) Stock Forecasts - Yahoo Finance
Enovis Corporation (ENOV) Stock Price, News, Quote & History - Yahoo! Finance Canada
Enovis Corporation (ENOV) stock price, news, quote and history - Yahoo Finance Singapore
Enovis expands support to AAOS Shoulder & Elbow... - Pluang
Enovis becomes first multi-registry industry sponsor of AAOS Registry Program - Stock Titan
Enovis Corp (ENOV) Shares Fall 4.6% -- What GF Score of 61 Tells Investors - GuruFocus
3 Reasons ENOV is Risky and 1 Stock to Buy Instead - Yahoo Finance
Insider at Medical Device Maker Buys More Than 7,500 Shares - finance.yahoo.com
Is It Too Late to Buy Enovis Corp (ENOV) After 4.7% Rally? GF Va - GuruFocus
Enovis stock hits 52-week low at 18.17 USD By Investing.com - Investing.com Australia
Enovis stock hits 52-week low at 18.17 USD - investing.com
Enovis CAO Oliver Engert buys $50,008 in company stock By Investing.com - Investing.com UK
Enovis CAO Oliver Engert buys $50,008 in company stock - investing.com
Enovis CORP (ENOV) insider adds 2,660 shares in open-market buy - Stock Titan
Enovis CORP CEO McDonald Damien Acquires 13,035 Shares at $19.15 on September 4, 2026 - Kalkine Media
Enovis at Wells Fargo healthcare conference: robotics push takes center stage - investing.com
Enovis Stock (ENOV) Opinions on eCential Robotics Acquisition - Quiver Quantitative
Enovis to acquire surgical tech provider eCential Robotics for $180M - The Robot Report
Enovis Corp (ENOV) CEO Damien Mcdonald Purchases 13,035 Shares - GuruFocus
Enovis CEO McDonald buys $249,620 in Enov shares By Investing.com - Investing.com Australia
Enovis CAO Oliver Engert buys $149,970 in company stock - investing.com
Enovis (NYSE: ENOV) CEO adds 13,035 shares in open-market buy - stocktitan.net
Enovis CEO McDonald buys $249,620 in Enov shares - Investing.com
Enovis (NYSE: ENOV) executive buys 7,598 shares outside 10b5-1 plan - Stock Titan
Is Enovis Corp (ENOV) a Bargain After 4.3% Drop? GF Value Says U - GuruFocus
Q2 Earnings Highlights: Enovis (NYSE:ENOV) Vs The Rest Of The Medical Devices & SuppliesSpecialty Stocks - Yahoo Finance
Enovis (ENOV) Stock Fair Value Falls As Analysts Weigh Robotics And Margin Pressure - Yahoo Finance
Enovis stock hits 52-week low at 19.12 USD By Investing.com - Investing.com South Africa
What Makes Enovis (ENOV) a New Buy Stock - Yahoo Finance
Enovis stock hits 52-week low at 19.12 USD - Investing.com
Enovis (ENOV) Loses 33% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
Citizens JMP Maintains Enovis Corp(ENOV.US) With Buy Rating, Cuts Target Price to $47 - moomoo.com
BMO cuts Enovis stock price target on margin headwinds from deal - Investing.com Australia
Enovis Is Maintained at Buy by Freedom Capital Markets - Moomoo
Enovis Boosts Surgical Robotics Portfolio With eCential Acquisition - Yahoo Finance
ENOV Maintained by Citizens -- Price Target Lowered to $47.00 - GuruFocus
Enovis inks eCential takeover to develop surgical ortho robots - Yahoo Finance
Enovis Is Maintained at Buy by BTIG - Moomoo
Citizens lowers Enovis stock price target on robotics acquisition - Investing.com
Citizens lowers Enovis stock price target on robotics acquisition By Investing.com - Investing.com Nigeria
Finanzdaten der Enovis Corp-Aktie (ENOV)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):